Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Nektar Therapeutics (ITH.F) Q4 2023 Earnings
ITH.F
4
Mar
Confirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.2
-0.2
-0.2
-0.19
Details
Expected EPS
-0.19387179691999998
Actual EPS
-0.2026772
Surprise EPS
-0.01
Surprise Percent
+4.54%
Description
Nektar Therapeutics (ITH.F) has reported earnings of -0.2026772 per share for Q4 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login